Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9436)
All Articles published online
|
Publishing Process of This Article
|
Mar 14, 2016 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yang W, Yan K, Goldberg SN, Ahmed M, Lee JC, Wu W, Zhang ZY, Wang S, Chen MH. Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment. World J Gastroenterol 2016; 22(10): 2993-3005 [PMID: 26973395 DOI: 10.3748/wjg.v22.i10.2993] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i10/2993.htm |
| Number | Citing Articles |
| 1 |
Yongrok Jeong, Jaeho Park, Jinwoo Lee, Kyuyoung Kim, Inkyu Park. Ultrathin, Biocompatible, and Flexible Pressure Sensor with a Wide Pressure Range and Its Biomedical Application. ACS Sensors 2020; 5(2): 481 doi: 10.1021/acssensors.9b02260
|
| 2 |
Jing Sun, Aimin Zhang, Wengang Li, Quan Wang, Jia Wang, Yuze Fan, Yingzhe Sun, Dong Li, Dan Zhang, Xuezhang Duan. CyberKnife Stereotactic Body Radiation Therapy as an Effective Treatment for Hepatocellular Carcinoma Patients With Decompensated Cirrhosis. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00100
|
| 3 |
Keizo Kato, Hiroshi Abe, Makiko Ika, Takeshi Yonezawa, Yoshiyuki Sato, Noriko Hanawa, Shohei Shimizu, Shinji Endo, Ryota Matsuo, Akihito Tsubota. C-Arm Cone Beam Computed Tomography Guidance for Radiofrequency Ablation in Hepatocellular Carcinoma. Oncology 2017; 92(3): 142 doi: 10.1159/000453665
|
| 4 |
Yuan-Hung Kuo, Tzu-Hsin Huang, Yi-Hao Yen, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen, Ming-Chao Tsai, Kwong-Ming Kee. Nomogram to Predict the Long-Term Overall Survival of Early-Stage Hepatocellular Carcinoma after Radiofrequency Ablation. Cancers 2023; 15(12): 3156 doi: 10.3390/cancers15123156
|
| 5 |
Garrett Richard Roll, John Paul Roberts. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set. 2019; : 1541 doi: 10.1016/B978-0-323-40232-3.00132-1
|
| 6 |
Xiu-Mei Bai, Zhong-Hu He, Hao Wu, Wei Yang, Song Wang, Zhong-Yi Zhang, Wei Wu, Kun Yan, Min-Hua Chen, S. Nahum Goldberg. An evaluation of 20-year survival of radiofrequency ablation for hepatocellular carcinoma as first-line treatment. European Journal of Radiology 2023; 168: 111094 doi: 10.1016/j.ejrad.2023.111094
|
| 7 |
Muhamad Serhal, Ahsun Riaz, Riad Salem, Robert J. Lewandowski. Gastrointestinal Malignancies. Cancer Treatment and Research 2024; 192: 207 doi: 10.1007/978-3-031-61238-1_11
|
| 8 |
Xu-Hua Duan, Hao Li, Xin-Wei Han, Jian-Zhuang Ren, Feng-Yao Li, Shu-Guang Ju, Peng-Fei Chen, Dong-Lin Kuang. Upregulation of IL-6 is involved in moderate hyperthermia induced proliferation and invasion of hepatocellular carcinoma cells. European Journal of Pharmacology 2018; 833: 230 doi: 10.1016/j.ejphar.2018.06.014
|
| 9 |
Xiu-Mei Bai, Wei Yang. Radiofrequency ablation of hepatocellular carcinoma: Prognostic factors and recent advances. World Chinese Journal of Digestology 2021; 29(13): 677 doi: 10.11569/wcjd.v29.i13.677
|
| 10 |
Peikun Li, Zhongshan Yu, Liang He, Dachen Zhou, Shengxue Xie, Hui Hou, Xiaoping Geng. Knockdown of FOXK1 inhibited the proliferation, migration and invasion in hepatocellular carcinoma cells. Biomedicine & Pharmacotherapy 2017; 92: 270 doi: 10.1016/j.biopha.2017.05.087
|
| 11 |
Mauro Giuffrè, Enrico Zuliani, Alessia Visintin, Paola Tarchi, Paola Martingano, Riccardo Pizzolato, Deborah Bonazza, Flora Masutti, Rita Moretti, Lory Saveria Crocè. Predictors of Hepatocellular Carcinoma Early Recurrence in Patients Treated with Surgical Resection or Ablation Treatment: A Single-Center Experience. Diagnostics 2022; 12(10): 2517 doi: 10.3390/diagnostics12102517
|
| 12 |
Zheng Fang, Bing Zhang, Wenjun Zhang. Advanced Computational Methods in Life System Modeling and Simulation. Communications in Computer and Information Science 2017; 761: 113 doi: 10.1007/978-981-10-6370-1_12
|
| 13 |
Jagpreet Chhatwal, Ali Hajjar, Peter P. Mueller, Gizem Nemutlu, Neeti Kulkarni, Mary Linton B. Peters, Fasiha Kanwal. Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C Individuals. Clinical Gastroenterology and Hepatology 2024; 22(1): 91 doi: 10.1016/j.cgh.2023.05.024
|
| 14 |
Yu-qing Du, Xiu-mei Bai, Wei Yang, Zhong-yi Zhang, Song Wang, Wei Wu, Kun Yan, Min-hua Chen. Percutaneous ultrasound-guided radiofrequency ablation for patients with liver metastasis from pancreatic adenocarcinoma. International Journal of Hyperthermia 2022; 39(1): 517 doi: 10.1080/02656736.2022.2048907
|
| 15 |
Jakob Weiss, Rüdiger Hoffmann, Hansjoerg Rempp, David‐Emanuel Keβler, Philippe L. Pereira, Konstantin Nikolaou, Stephan Clasen. Feasibility, efficacy, and safety of percutaneous MR‐guided ablation of small (≤12 mm) hepatic malignancies. Journal of Magnetic Resonance Imaging 2019; 49(2): 374 doi: 10.1002/jmri.26252
|
| 16 |
Peter P. Mueller, Qiushi Chen, Turgay Ayer, Gizem S. Nemutlu, Ali Hajjar, Emily D. Bethea, Mary Linton B. Peters, Brian P. Lee, Naveed Z. Janjua, Fasiha Kanwal, Jagpreet Chhatwal. Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication. Journal of Hepatology 2022; 77(1): 55 doi: 10.1016/j.jhep.2022.01.027
|
| 17 |
Fanyu Meng, Haoyun Zhang, Haiwen Peng, Shichun Lu, Min Tang. Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/6638117
|
| 18 |
Mingheng Liao, Xiaofei Zhong, Jingyi Zhang, Yangyang Liu, Zexin Zhu, Hong Wu, Yong Zeng, Jiwei Huang. Radiofrequency ablation using a 10‐mm target margin for small hepatocellular carcinoma in patients with liver cirrhosis: A prospective randomized trial. Journal of Surgical Oncology 2017; 115(8): 971 doi: 10.1002/jso.24607
|
| 19 |
Jagpreet Chhatwal, Sumeyye Samur, Ju Dong Yang, Lewis R. Roberts, Mindie H. Nguyen, A. Burak Ozbay, Turgay Ayer, Neehar D. Parikh, Amit G. Singal. Effectiveness of HCC surveillance programs using multitarget blood test: A modeling study. Hepatology Communications 2023; 7(6) doi: 10.1097/HC9.0000000000000146
|
| 20 |
Valtteri KAIRALUOMA, Mira KARJALAINEN, Vesa-Matti POHJANEN, Juha SAARNIO, Jarmo NIEMELÄ, Heikki HUHTA, Olli HELMINEN. Treatment trends and outcomes of hepatocellular carcinoma in a single center for 35 years. Minerva Surgery 2021; 76(3) doi: 10.23736/S2724-5691.21.08426-1
|
| 21 |
Jeong Hee Yoon, Won Chang, Eun Sun Lee, Sang Min Lee, Jeong Min Lee. Double Low-Dose Dual-Energy Liver CT in Patients at High-Risk of HCC. Investigative Radiology 2020; 55(6): 340 doi: 10.1097/RLI.0000000000000643
|
| 22 |
Carlo Felix Maria Jung, Elisa Liverani, Cecilia Binda, Ludovica Cristofaro, Alberto Gori, Luigina Vanessa Alemanni, Alessandro Sartini, Chiara Coluccio, Giulia Gibiino, Chiara Petraroli, Carla Serra, Carlo Fabbri. Non-Operating Room Anesthesia (NORA) for Ultrasound-Guided Liver Radiofrequency Ablation. Diagnostics 2024; 14(16): 1783 doi: 10.3390/diagnostics14161783
|
| 23 |
Genevieve Jingwen Tan, Chau Hung Lee, Yan Sun, Cher Heng Tan. Is non-contrast-enhanced magnetic resonance imaging cost-effective for screening of hepatocellular carcinoma?. Singapore Medical Journal 2024; 65(1): 23 doi: 10.11622/smedj.2021153
|
| 24 |
Wei-Yu Kao, Chien-Wei Su, Yi-You Chiou, Nai-Chi Chiu, Chien-An Liu, Kuan-Chieh Fang, Teh-Ia Huo, Yi-Hsiang Huang, Chun-Chao Chang, Ming-Chih Hou, Han-Chieh Lin, Jaw-Ching Wu. Hepatocellular Carcinoma: Nomograms Based on the Albumin-Bilirubin Grade to Assess the Outcomes of Radiofrequency Ablation. Radiology 2017; 285(2): 670 doi: 10.1148/radiol.2017162382
|
| 25 |
Zhong-Xing Shi, Chang-Fu Li, Li-Feng Zhao, Zhong-Qi Sun, Li-Ming Cui, Yan-Jie Xin, Dong-Qing Wang, Tan-Rong Kang, Hui-Jie Jiang. Computed tomography radiomic features and clinical factors predicting the response to first transarterial chemoembolization in intermediate-stage hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2024; 23(4): 361 doi: 10.1016/j.hbpd.2023.06.011
|
| 26 |
Qi-fan He, Yue Xiong, Yi-hui Yu, Xiang-chao Meng, Tian-xu Ma, Zhong-hua Chen. Retrospective Analysis of Radiofrequency Ablation in Patients with Small Solitary Hepatocellular Carcinoma: Survival Outcomes and Development of a Machine Learning Prognostic Model. Current Medical Science 2024; 44(5): 1006 doi: 10.1007/s11596-024-2900-4
|
| 27 |
Dimitrios S. Karagiannakis. Systemic Treatment in Intermediate Stage (Barcelona Clinic Liver Cancer-B) Hepatocellular Carcinoma. Cancers 2023; 16(1): 51 doi: 10.3390/cancers16010051
|
| 28 |
Ashwin Shinde, Bernard L. Jones, Yi-Jen Chen, Arya Amini. Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma: Does Radiation Dose Make a Difference?. Journal of Clinical Oncology 2018; 36(24): 2566 doi: 10.1200/JCO.2018.78.6012
|
| 29 |
Delia D’Avola, Alessandro Granito, Manuel de la Torre-Aláez, Fabio Piscaglia. The importance of liver functional reserve in the non-surgical treatment of hepatocellular carcinoma. Journal of Hepatology 2022; 76(5): 1185 doi: 10.1016/j.jhep.2021.11.013
|
| 30 |
Qingsong Deng, Minglian He, Chunchuan Fu, Kai Feng, Kuansheng Ma, Leida Zhang. Radiofrequency ablation in the treatment of hepatocellular carcinoma. International Journal of Hyperthermia 2022; 39(1): 1052 doi: 10.1080/02656736.2022.2059581
|
| 31 |
Yuanfeng Meng, Binbin Jiang, Kun Yan, Song Wang, Zhongyi Zhang, Luzeng Chen, Wei Wu, Wei Yang. Evaluation of the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation for hepatocellular carcinoma and liver metastases adjacent to the gallbladder. International Journal of Hyperthermia 2023; 40(1) doi: 10.1080/02656736.2023.2182748
|
| 32 |
Jin-Yu Wu, Xiu-Mei Bai, Hong Wang, Qian Xu, Song Wang, Wei Wu, Kun Yan, Wei Yang. The Perfusion Features of Recurrent Hepatocellular Carcinoma After Radiofrequency Ablation Using Contrast-Enhanced Ultrasound and Pathological Stemness Evaluation: Compared to Initial Tumors. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01464
|
| 33 |
Jing-Jing Fu, Song Wang, Wei Yang, Wei Gong, An-Na Jiang, Kun Yan, Min-Hua Chen. Protective and Heat Retention Effects of Thermo-sensitive Basement Membrane Extract (Matrigel) in Hepatic Radiofrequency Ablation in an Experimental Animal Study. CardioVascular and Interventional Radiology 2017; 40(7): 1077 doi: 10.1007/s00270-017-1617-1
|
| 34 |
Riccardo Memeo, Patrick Pessaux, Nicola Silvestris, Oronzo Brunetti, Antonio Giovanni Solimando, Andrea Casadei Gardini. Practical Medical Oncology Textbook. UNIPA Springer Series 2021; : 689 doi: 10.1007/978-3-030-56051-5_42
|
| 35 |
Anh Le Tuan Nguyen, Christopher Leigh Blizzard, Kwang Chien Yee, Julie A. Campbell, Andrew J. Palmer, Barbara de Graaff. Hospitalisation costs of primary liver cancer in Australia: evidence from a data-linkage study. Australian Health Review 2022; 46(4): 463 doi: 10.1071/AH21395
|
| 36 |
Hyo-Jin Kang, Jeong Min Lee, Chulkyun Ahn, Jae Seok Bae, Seungchul Han, Se Woo Kim, Jeong Hee Yoon, Joon Koo Han. Low dose of contrast agent and low radiation liver computed tomography with deep-learning-based contrast boosting model in participants at high-risk for hepatocellular carcinoma: prospective, randomized, double-blind study. European Radiology 2023; 33(5): 3660 doi: 10.1007/s00330-023-09520-4
|
| 37 |
Mohamed Hisham Aref, Ibrahim H. Aboughaleb, Yasser H. El-Sharkawy. Tissue characterization utilizing hyperspectral imaging for liver thermal ablation. Photodiagnosis and Photodynamic Therapy 2020; 31: 101899 doi: 10.1016/j.pdpdt.2020.101899
|
| 38 |
Yun Mou, Qiyu Zhao, Liyun Zhong, Fen Chen, Tianan Jiang. Preliminary results of ultrasound-guided laser ablation for unresectable metastases to retroperitoneal and hepatic portal lymph nodes. World Journal of Surgical Oncology 2016; 14(1) doi: 10.1186/s12957-016-0917-2
|
| 39 |
Matteo Canale, Paola Ulivi, Francesco Giuseppe Foschi, Emanuela Scarpi, Serena De Matteis, Gabriele Donati, Giorgio Ercolani, Mario Scartozzi, Luca Faloppi, Alessandro Passardi, Emiliano Tamburini, Martina Valgiusti, Giorgia Marisi, Giovanni Luca Frassineti, Andrea Casadei Gardini. Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma. Critical Reviews in Oncology/Hematology 2018; 129: 44 doi: 10.1016/j.critrevonc.2018.06.017
|
| 40 |
Zhi‐Yuan Chen, Zhi‐Xing Guo, Liang‐He Lu, Jie Mei, Wen‐Ping Lin, Shao‐Hua Li, Wei Wei, Rong‐Ping Guo. The predictive value of vessels encapsulating tumor clusters in treatment optimization for recurrent early‐stage hepatocellular carcinoma. Cancer Medicine 2021; 10(16): 5466 doi: 10.1002/cam4.4102
|
| 41 |
B. I. Dolgushin, V. Yu. Kosyrev, E. R. Virshke, V. N. Sholokhov, D. V. Martynkov. Radiofrequency thermal destruction in current treatment of liver malignancies. Literature review. Annaly khirurgicheskoy gepatologii = Annals of HPB surgery 2018; 23(2): 11 doi: 10.16931/1995-5464.2018211-25
|
| 42 |
Yong Zhu He, Kun He, Rui Qin Huang, Li Wen Liu, Shao Wei Ye, Jun Lin Qian, Peng Peng, Qi Jie Luo, Ze Liang Wang, Ze Min Hu. A clinical scoring system for predicting tumor recurrence after percutaneous radiofrequency ablation for 3 cm or less hepatocellular carcinoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-87782-y
|
| 43 |
Ahmed Salman, Mohamed Salman, Ahmed Moustafa, Hossam El-Din Shaaban, Ahmed El-Mikkawy, Safa Labib, Ahmed Youssef, Mahmoud Gouda Omar, Mohamed Matter, Hesham Elkassar. Impact of Sarcopenia on Two-Year Mortality in Patients with HCV-Associated Hepatocellular Carcinoma After Radiofrequency Ablation. Journal of Hepatocellular Carcinoma 2021; : 313 doi: 10.2147/JHC.S300680
|
| 44 |
Amar Mukund, Prayas Vats, Ankur Jindal, Yashwant Patidar, Shiv K. Sarin. Early Hepatocellular Carcinoma Treated by Radiofrequency Ablation—Mid- and Long-Term Outcomes. Journal of Clinical and Experimental Hepatology 2020; 10(6): 563 doi: 10.1016/j.jceh.2020.04.016
|
| 45 |
Pantzios Spyridon, Syriha Antonia, Mandilara Dionysia, Stathopoulou Ioanna, Barla Georgia, Ptohis Nikolaos, Galanis Petros, Elefsiniotis Ioannis. Efficacy of Αtezolizumab–Βevacizumab in BCLC-C cirrhotic patients with hepatocellular carcinoma according to the type of disease progression, the type of BCLC-C and liver disease severity. Journal of Cancer Research and Clinical Oncology 2023; 149(11): 9253 doi: 10.1007/s00432-023-04846-4
|
| 46 |
Wei Yang, Kun Yan, Min-Hua Chen, Jin-Yu Wu, Zhong-Yi Zhang, Jung-Chieh Lee, Song Wang, Wei Wu. Preliminary experience with direct percutaneous arterial embolisation combined with radiofrequency ablation for hypervascular HCC. International Journal of Hyperthermia 2017; : 1 doi: 10.1080/02656736.2017.1305126
|
| 47 |
Alessandro Granito, Luigi Bolondi. Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis. The Lancet Oncology 2017; 18(2): e101 doi: 10.1016/S1470-2045(16)30569-1
|
| 48 |
Xiu-Mei Bai, Ming Cui, Wei Yang, Hong Wang, Song Wang, Zhong-Yi Zhang, Wei Wu, Min-Hua Chen, Kun Yan, S. Nahum Goldberg. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC. Radiology 2021; 300(2): 458 doi: 10.1148/radiol.2021200153
|
| 49 |
Shicheng Zhou, Terrence Chi Hong Hui, Uei Pua. Percutaneous thermal ablation of hepatocellular carcinoma in the older population. Journal of Geriatric Oncology 2020; 11(7): 1161 doi: 10.1016/j.jgo.2020.03.004
|
| 50 |
Chenyang Qiu, Yinchao Ma, Mengjun Xiao, Zhipeng Wang, Shuzhen Wu, Kun Han, Haiyan Wang. Nomogram to Predict Tumor Remnant of Small Hepatocellular Carcinoma after Microwave Ablation. Academic Radiology 2024; doi: 10.1016/j.acra.2024.09.066
|
| 51 |
Jingru Pan, Xianlong Li, Ye He, Chaojun Jian, Hui-xin Chen, Ziqing Hei, Shaoli Zhou. Comparison of dexmedetomidine vs. remifentanil combined with sevoflurane during radiofrequency ablation of hepatocellular carcinoma: a randomized controlled trial. Trials 2019; 20(1) doi: 10.1186/s13063-018-3010-z
|
| 52 |
Carlos Moctezuma-Velazquez, Aldo J. Montano-Loza, Judith Meza-Junco, Kelly Burak, Mang Ma, Vincent G. Bain, Norman Kneteman, Phillipe Sarlieve, Richard J. Owen. Selective Internal Radiation Therapy for Hepatocellular Carcinoma Across the Barcelona Clinic Liver Cancer Stages. Digestive Diseases and Sciences 2021; 66(3): 899 doi: 10.1007/s10620-020-06245-y
|
| 53 |
Wan Yee Lau, Stephanie Hiu Yan Lau. The current role of radiofrequency ablation in the treatment of hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2017; 16(2): 122 doi: 10.1016/S1499-3872(16)60182-0
|
| 54 |
Xue-Song Yao, Dong Yan, Xian-Xian Jiang, Xiao Li, Hui-Ying Zeng, Huai Li. Short-term outcomes of radiofrequency ablation for hepatocellular carcinoma using cone-beam computed tomography for planning and image guidance. World Journal of Clinical Cases 2021; 9(7): 1580-1591 doi: 10.12998/wjcc.v9.i7.1580
|
| 55 |
Jeffrey L. Weinstein, Muneeb Ahmed. Percutaneous Ablation for Hepatocellular Carcinoma. American Journal of Roentgenology 2018; 210(6): 1368 doi: 10.2214/AJR.17.18695
|